With future in sight, GSK sells it stake in respiratory drug firm Innoviva

May 26, 2021

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

April 22, 2026

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

August 17, 2026

Must Read

Quantum Computing and Drug Discovery

August 20, 2026

After a GLP-1 inhibitor lowers blood sugar crashes in a Ph. 3 victory, Amylyx prepares to push for approval

August 20, 2026

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

August 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Definium Bags Major Phase 3 Victory With LSD Formula

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

MoonLake Reports Positive Phase 3 Results for Sonelokimab in Psoriatic Arthritis

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Zealand Bags Huge Money By Selling Rights to Takeda’s Blood Cancer Drug

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Quantum Computing and Drug Discovery

Why Data Is Becoming Pharma’s Most Valuable Asset

Reinventing the Pharmaceutical Commercial Model

Top 10 Strategic Priorities for Pharma CEOs in 2027

Tag: digital drug delivery

Most life sciences executives say digital delivery of drugs is the future of health

Editor Picks

With future in sight, GSK sells it stake in respiratory drug firm Innoviva

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Taiho and Cullinan Report Phase 3 Progression-Free Survival Win for Zipalertinib

Must Read

Quantum Computing and Drug Discovery

After a GLP-1 inhibitor lowers blood sugar crashes in a Ph. 3 victory, Amylyx prepares to push for approval

Biokin’s Iza-Bren Meets Primary Endpoint in Phase 3 Panku-Lung01 Lung Cancer Trial

Hot Topics

About Us

Follow Us